Tag: narrow therapeutic index

3 July 2026 0 Comments Tessa Marley

Why Generic Switching Raises Concerns for NTI Drugs: Risks, Regulations, and Patient Safety

Discover why switching generic versions of Narrow Therapeutic Index (NTI) drugs like Warfarin and Phenytoin poses unique risks. Learn about bioequivalence gaps, regulatory debates, and how to protect your health.

Continue Reading...
7 February 2026 13 Comments Tessa Marley

Carbamazepine Generics: Enzyme Induction and Drug Interactions Explained

Carbamazepine generics may look identical, but differences in formulation can cause dangerous drops in blood levels, increased seizures, or toxic side effects. Learn why enzyme induction and narrow therapeutic index make this drug uniquely risky when switching generics.

Continue Reading...